In a groundbreaking move, Merck and the Medicines Patent Pool ink a licensing deal for a COVID-19 pill

October 27, 2021 |
U.S. drug company Merck to share license for experimental covid-19 treatment with non-profit
Merck expands manufacturing for molnupiravir. But questions remain.
Related Posts
Access to Medicines

Pharma Pricing Secrecy Run...
Funding the Fight

Congress’s Spending Bill...
Health Justice

PEPFAR can’t kee...